Andersons pediatric cardiology 1585

124.JacobsJF,WillemsenMA,Groot-LoonenJJ,
WeversRA,HoogerbruggePM.Allogeneic
BMTfollowedbysubstratereductiontherapyin
achildwithsubacuteTay-sachsdisease.Bone
MarrowTransplant.2005;36(1):925–926.
125.Cachon-GonzalezMB,WangSZ,LynchA,etal.
Effectivegenetherapyinanauthenticmodelof
Tay-sachs-relateddiseases.ProcNatlAcadSci
USA.2006;103(27):10373–10378.
126.BembiB,MarchettiF,GuerciVI,etal.Substrate
reductiontherapyintheinfantileformofTaysachsdisease.Neurology.2006;66(2):278–280.
127.LawsonCA,MartinDR.AnimalmodelsofGM2
gangliosidosis:utilityandlimitations.ApplClin
Genet.2016;9:111–120.
128.SalmanMS,ClarkeJT,MidroniG,Waxman
MB.Peripheralandautonomicnervoussystem
involvementinchronicGM2-gangliosidosis.J
InheritMetabDis.2001;24(1):65–71.
129.BliedenLC,DesnickRJ,CarterJB,etal.
CardiacmalformationsinSandhoff'sdisease.
Inbornerrorofglycosphyngolipidmetabolism.
AmJCardiol.1974;34:83–88.
130.VenugopalanP,JoshiSN.Cardiacinvolvement
insandhoffdisease.JPaediatrChildHealth.
2002;38(1):98–100.
131.BliedenLB,MollerJH.Cardiacinvolvementin


inheriteddisordersofmetabolism.Prog
CardiovascDis.1974;16:615–631.
132.Mayer-DavisEJ,LawrenceJM,DabeleaD,etal.

IncidencetrendsoftypeIandtype2diabetes
amongyouths,2002-2012.NEnglJMed.
2017;376:1419–1429.
133.BliedenLB,MollerJH.Cardiacinvolvementin
inheriteddisordersofmetabolism.Prog
CardiovascDis.1974;16:615–631.
134.LisowskiLA,VerheijenPM,CopelJA,etal.
Congenitalheartdiseaseinpregnancies
complicatedbymaternaldiabetesmellitus.Herz.
2010;35:19–26.
135.BloomA,HayesTM,GambleDR.Registryof
newlydiagnoseddiabeticchildren.BrMedJ.
1975;3:580–583.
136.CrossleyJR,UpsdellM.Theincidenceof
juvenilediabetesmellitusinNewZealand–34.
Diabetologia.1980;18:29.
137.FisherBM,ClelandJGF,DargieHJ,FrierBM.
Non-invasiveevaluationofcardiacfunctionin
youngpatientswithtype1diabetes.DiabetMed.
1989;6:677–681.
138.RellerMD,TsangRC,MeyerRA,BraunCP.
Relationshipofprospectivediabetescontrolin
pregnancytoneonatalcardiorespiratory
function.JPediatr.1985;106(1):86–90.


139.RellerMD,KaplanS.Hypertrophic
cardiomyopathyininfantsofdiabeticmothers:
anupdate.AmJPerinatol.1998;5(4):353–358.
140.MoscaS,PaulilloS,ColaoA,etal.

Cardiovascularinvolvementinpatientsaffected
byacromegaly:anappraisal.IntJCardiol.
2013;167:1712–1718.
141.SchwarzER,JammulaP,GuptaR,RosanioS.A
caseandreviewofacromegaly-induced
cardiomyopathyandtherelationshipbetween
growthhormoneandheartfailure:causeorcure
orneitherorboth?JCardiovascPharmacol
Ther.2006;11(4):232–244.
142.RondaniniGF,deDanizzaG,BollatiA,etal.
Congenitalhypothyroidismandpericardial
effusion.HormRes.1991;35:41–44.
143.Loomba-AlbrechtLA,BremerAA,StyneDM,et
al.Highfrequencyofcardiacandbehavioral
complaintsaspresentingsymptomsof
hyperthyroidisminchildren.JPediatr
EndocrinolMetab.2011;24(3–4):209–213.
144.ChannickRJ,AdlinEV,MarksAD,etal.
Hyperthyroidismwithmitralvalveprolapse.N
EnglJMed.1981;305:497–500.
145.BraumanA,AlgomM,GilboaY,etal.Mitral
valveprolapseinhyperthyroidismoftwo
differentorigins.BrHeartJ.1985;53:374–377.